Tumor-associated antigen expressing listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Olino, Kelly ^a   Wada, Satoshi ^a   Edil, Barish H ^a   Pan, Xiaoyu ^a   Meckel, Kristen ^a   Weber, Walter ^a   Slansky, Jill ^b   Tamada, Koji ^c   Lauer, Peter ^d   Brockstedt, Dirk ^d   Pardoll, Drew ^a   Schulick, Richard ^a   Yoshimura, Kiyoshi ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Aduro BioTech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BACTERIAL PROTEIN; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERNALIN B; LMD AH1 PROTEIN; LMD PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL POPULATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; HEPATIC COLORECTAL CANCER METASTASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LISTERIA MONOCYTOGENES; LIVER METASTASIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; TUMOR MICROENVIRONMENT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COLONIC NEOPLASMS; CTLA-4 ANTIGEN; CYCLOPHOSPHAMIDE; FEMALE; IMMUNOTHERAPY; INTERFERON-GAMMA; LISTERIA MONOCYTOGENES; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84865034591     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2037-0     Document Type: Article

References (37)

1. MT Hueman ZA Dehqanzada TE Novak, et al. 2005 Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients Clin Cancer Res. 11 7470 7479 16243821 10.1158/1078-0432.CCR-05-0235 1:CAS:528:DC%2BD2MXhtFartbvE
2. EM Jaffee RH Hruban B Biedrzycki, et al. 2001 Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation J Clin Oncol. 19 145 156 11134207 1:CAS:528:DC%2BD3MXot1WgtQ%3D%3D
3. LE Johnson TP Frye AR Arnot, et al. 2006 Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP) Vaccine. 24 293 303 16115700 10.1016/j.vaccine.2005.07.074 1:CAS:528:DC%2BD2MXhtlaitL%2FL
4. GE Peoples JP Holmes MT Hueman, et al. 2008 Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 Clin Cancer Res. 14 797 803 18245541 10.1158/1078-0432.CCR-07-1448 1:CAS:528:DC%2BD1cXhsFykt7o%3D
5. RK Ramanathan KM Lee J McKolanis, et al. 2005 Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer Cancer Immunol Immunother. 54 254 264 15372205 10.1007/s00262-004-0581-1 1:CAS:528:DC%2BD2MXjs1ahuw%3D%3D
6. + T cells Int J Mol Med. 14 571 576 15375583 1:CAS:528:DC%2BD2cXovFWnt74%3D
7. T Kawaoka M Oka M Takashima, et al. 2008 Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1 Oncology Rep. 20 155 163
8. H Kondo S Hazama T Kawaoka, et al. 2008 Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes Anticancer Res. 28 379 387 18383873 1:CAS:528:DC%2BD1cXkt1Kntrc%3D
9. K Yoshimura S Hazama N Iizuka, et al. 2001 Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence Cancer Gene Ther. 8 9 16 11219497 10.1038/sj.cgt.7700277 1:CAS:528:DC%2BD3MXhtlWntLg%3D
10. ME Dudley JC Yang R Sherry, et al. 2008 Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol. 26 5233 5239 18809613 10.1200/JCO.2008.16.5449 1:CAS:528:DC%2BD1cXhsVyqsrbO
11. FS Hodi MC Mihm RJ Soiffer, et al. 2003 Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Proc Natl Acad Sci USA. 100 4712 4717 12682289 10.1073/pnas.0830997100 1:CAS:528:DC%2BD3sXjt12nsL4%3D
12. CW Chan E Crafton HN Fan, et al. 2006 Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity Nat Med. 12 207 213 16444266 10.1038/nm1352 1:CAS:528:DC%2BD28XhtFWqu70%3D
13. M Pletneva H Fan JJ Park, et al. 2009 IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity Cancer Res. 69 6607 6614 19679552 10.1158/0008-5472.CAN-09-0508 1:CAS:528:DC%2BD1MXpvFejtL0%3D
14. K Yoshimura LS Laird CY Chia, et al. 2007 Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells Cancer Res. 67 10058 10066 17942940 10.1158/0008-5472.CAN-07-0573 1:CAS:528:DC%2BD2sXhtFOnsLjM
15. DP Griswold TH Corbett 1975 A colon tumor model for anticancer agent evaluation Cancer. 36 2441 2444 1212662 10.1002/1097-0142(197512)36:6<2441:: AID-CNCR2820360627>3.0.CO;2-P 1:STN:280:DyaE287hs1Shsw%3D%3D
16. TH Corbett DP Griswold Jr BJ Roberts JC Peckham FM Schabel Jr 1975 Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure Cancer Res. 35 2434 2439 1149045 1:CAS:528:DyaE2MXlsFyru7k%3D
17. SH Kim F Castro Y Paterson C Gravekamp 2009 High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action Cancer Res. 69 5860 5866 19584282 10.1158/0008-5472.CAN-08-4855 1:CAS:528:DC%2BD1MXosV2msbs%3D
18. MM Seavey ZK Pan PC Maciag, et al. 2009 A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors Clin Cancer Res. 15 924 932 19188163 10.1158/1078-0432.CCR-08-2283 1:CAS:528:DC%2BD1MXht1Onsbg%3D
19. + T cells by polyvalent Listeria monocytogenes-based vaccines J Immunother. 32 856 869 19752748 10.1097/CJI.0b013e3181b0b125 1:CAS:528:DC%2BD1MXhtFGksbjP
20. Francisco LM, Salinas VH, Brown KE, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. (in press).
21. GJ Freeman AJ Long Y Iwai, et al. 2000 Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med. 192 1027 1034 11015443 10.1084/jem.192.7.1027 1:CAS:528:DC%2BD3cXntFSlt7o%3D
22. AH Sharpe EJ Wherry R Ahmed GJ Freeman 2007 The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection Nat Immunol. 8 239 245 17304234 10.1038/ni1443 1:CAS:528:DC%2BD2sXhslWms78%3D
23. AY Huang PH Gulden AS Woods, et al. 1996 The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product Proc Natl Acad Sci USA. 93 9730 9735 8790399 10.1073/pnas.93.18.9730 1:CAS:528:DyaK28XlsFehsL8%3D
24. DG Brockstedt MA Giedlin ML Leong, et al. 2004 Listeria-based cancer vaccines that segregate immunogenicity from toxicity Proc Natl Acad Sci USA. 101 13832 13837 15365184 10.1073/pnas.0406035101 1:CAS:528:DC%2BD2cXotVygtLc%3D
25. P Lauer MY Chow MJ Loessner DA Portnoy R Calendar 2002 Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors J Bacteriol. 184 4177 4186 12107135 10.1128/JB.184.15.4177- 4186.2002 1:CAS:528:DC%2BD38XlsVGnsbc%3D
26. K Yoshimura A Jain HE Allen, et al. 2006 Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes Cancer Res. 66 1096 1104 16424046 10.1158/0008-5472.CAN-05-2307 1:CAS:528: DC%2BD28XlsFOgtw%3D%3D
27. S Wada K Yoshimura EL Hipkiss, et al. 2009 Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model Cancer Res. 69 4309 4318 19435909 10.1158/0008-5472.CAN-08-4102 1:CAS:528: DC%2BD1MXlvFWltLc%3D
28. SN Mueller CM Jones CM Smith WR Heath FR Carbone 2002 Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus J Exp Med. 195 651 656 11877488 10.1084/jem.20012023 1:CAS:528:DC%2BD38XitV2nu7k%3D
29. JH Rowe TM Johanns JM Ertelt JC Lai SS Way 2009 Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge Immunology. 128 e471 e478 19191906 10.1111/j.1365-2567.2008.03001.x
30. + T lymphocytes Nature. 421 852 856 12594515 10.1038/nature01441 1:CAS:528:DC%2BD3sXht1KqtLo%3D
31. + T cells in primary and secondary responses Proc Natl Acad Sci USA. 107 193 198 19966302 10.1073/pnas.0909945107 1:CAS:528: DC%2BC3cXnsFCmug%3D%3D
32. + T cell precursor can develop into diverse effector and memory subsets Immunity. 27 985 997 18082432 10.1016/j.immuni.2007.10.012 1:CAS:528:DC%2BD1cXotFaq
33. FC Stark S Sad L Krishnan 2009 Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection Cancer Res. 69 4327 4334 19435919 10.1158/0008-5472.CAN-08-3160 1:CAS:528:DC%2BD1MXlvFWltb8%3D
34. BT Fife JA Bluestone 2008 Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways Immunol Rev. 224 166 182 18759926 10.1111/j.1600-065X.2008.00662.x 1:CAS:528:DC%2BD1cXhtF2qurnE
35. BT Fife KE Pauken TN Eagar, et al. 2009 Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal Nat Immunol. 10 1185 1192 19783989 10.1038/ni.1790 1:CAS:528:DC%2BD1MXhtFygsLjL
36. DG Brockstedt TW Dubensky 2008 Promises and challenges for the development of Listeria monocytogenes-based immunotherapies Exp Rev Vaccines. 7 1069 1084 10.1586/14760584.7.7.1069
37. + T-cell memory formation, function, and maintenance Proc Natl Acad Sci USA. 108 266 271 21173239 10.1073/pnas.1016791108 1:CAS:528:DC%2BC3MXms1Khsg%3D%3D